These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8179151)

  • 21. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug.
    Savarese JJ; Ali HH; Basta SJ; Embree PB; Scott RP; Sunder N; Weakly JN; Wastila WB; el-Sayad HA
    Anesthesiology; 1988 May; 68(5):723-32. PubMed ID: 2967039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unexpected prolonged neuromuscular block after mivacurium: a case report.
    Hemadri M; Purva M; Traykova V
    Med Princ Pract; 2002; 11(1):50-2. PubMed ID: 12116697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suxamethonium and mivacurium sensitivity from pregnancy-induced plasma cholinesterase deficiency.
    Davies P; Landy M
    Anaesthesia; 1998 Nov; 53(11):1109-11. PubMed ID: 10023281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacodynamics and the plasma concentration of mivacurium during spontaneous recovery and neostigmine-facilitated recovery.
    Lien CA; Belmont MR; Wray Roth DL; Okamoto M; Abalos A; Savarese JJ
    Anesthesiology; 1999 Jul; 91(1):119-26. PubMed ID: 10422936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re-establishment of paralysis after recovery from mivacurium block.
    Feldman S
    Anaesthesia; 1996 May; 51(5):504-5. PubMed ID: 8694179
    [No Abstract]   [Full Text] [Related]  

  • 26. Prolonged neuromuscular block associated with mivacurium.
    Fox MH; Hunt PC
    Br J Anaesth; 1995 Feb; 74(2):237-8. PubMed ID: 7696077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of neuromuscular monitoring to detect prolonged effect of succinylcholine or mivacurium: three case reports.
    Cassel J; Staehr-Rye AK; Nielsen CV; Gätke MR
    Acta Anaesthesiol Scand; 2014 Sep; 58(8):1040-3. PubMed ID: 24947746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzymatic versus pharmacologic antagonism of profound mivacurium- induced neuromuscular blockade.
    Naguib M; Selim M; Bakhamees HS; Samarkandi AH; Turkistani A
    Anesthesiology; 1996 May; 84(5):1051-9. PubMed ID: 8623998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neostigmine but not edrophonium prolongs the action of mivacurium.
    Symington MJ; Mirakhur RK; Kumar N
    Can J Anaesth; 1996 Dec; 43(12):1220-3. PubMed ID: 8955970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recovery from mivacurium block with or without anticholinesterase following continuous infusion in obstetric patients.
    Jan GS; Tong WN; Chan AM; Hui TW; Lo JW
    Anaesth Intensive Care; 1996 Oct; 24(5):585-9. PubMed ID: 8909671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mivacurium-induced prolonged neuromuscular block.
    Sockalingam I; Green DW
    Br J Anaesth; 1995 Feb; 74(2):234-6. PubMed ID: 7696076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Edrophonium antagonism of intense mivacurium-induced neuromuscular block in children.
    Abdulatif M; Al-Ghamdi A; Al-Sanabary M; Abdel-Gaffar ME
    Br J Anaesth; 1996 Feb; 76(2):239-44. PubMed ID: 8777104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacodynamics of mivacurium in infants.
    Meretoja OA; Taivainen T; Wirtavuori K; Olkkola KT
    Br J Anaesth; 1994 Oct; 73(4):490-3. PubMed ID: 7695717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neostigmine and edrophonium. Antagonism of profound and shallow mivacurium blockade].
    Bartunek A; Gilly H; Huemer G; Yildiz S; Schramm W; Lackner FX; Foldes FF
    Anaesthesist; 1997 Feb; 46(2):96-100. PubMed ID: 9133184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Plasma cholinesterase variations as a result of prolonged neuromuscular blockade. Review and problems encountered in two cases of prolonged neuromuscular blockade after muscle relaxation with succinylcholine as compared to mivacurium].
    Lang C; Lukasewitz P; Wulf H; Geldner G
    Anaesthesist; 2002 Feb; 51(2):134-41. PubMed ID: 11963306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neuromuscular and cardiovascular effect of mivacurium in anesthesia induction in patients with renal failure].
    Blobner M; Jelen-Esselborn S; Mann R; Kling M; Schneider G; Schneck HJ; Kochs E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Feb; 31(1):15-21. PubMed ID: 8868527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose responses for neostigmine and edrophonium as antagonists of mivacurium in adults and children.
    Bevan JC; Tousignant C; Stephenson C; Blackman L; Reimer E; Smith MF; Bevan DR
    Anesthesiology; 1996 Feb; 84(2):354-61. PubMed ID: 8602666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mivacurium sensitivity in a patient heterozygous for the atypical and silent genes for plasma cholinesterase.
    Robertson WS; Shaikh J; Purdie DW
    Ann Clin Biochem; 1995 Jul; 32 ( Pt 4)():431-3. PubMed ID: 7486808
    [No Abstract]   [Full Text] [Related]  

  • 39. Mivacurium in the myasthenic patient.
    Paterson IG; Hood JR; Russell SH; Weston MD; Hirsch NP
    Br J Anaesth; 1994 Oct; 73(4):494-8. PubMed ID: 7999490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuromuscular and hemodynamic effects of mivacurium and succinylcholine in adult patients during nitrous oxide-propofol-fentanyl anesthesia.
    Hwang KH; Kim SC; Kim SY; Ueda N; Muteki T
    J Korean Med Sci; 1993 Oct; 8(5):374-9. PubMed ID: 8305145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.